Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [
A phase 3 trial of Atezolizumab, Cisplatin, Vinorelbine in non-small-cell lung cancer and small-cell lung cancer, run by Hoffmann-La Roche, active and no longer recruiting.
Overview
Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010] is a phase 3 interventional study registered as NCT02486718 by Hoffmann-La Roche, with 1280 participants enrolled, started 2015-10-31 and due to reach its primary completion in 2024-01-26. Interventions recorded: Atezolizumab, Cisplatin, Vinorelbine, Docetaxel, Gemcitabine. Conditions listed: Non-Small Cell Lung Cancer. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialA Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)
Shares Atezolizumab, Roche / Genentech, Pemetrexed, Gemcitabine.
- TrialA Study of Atezolizumab in High PD-L1 Expression, Chemotherapy-Naïve Patients With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer
Shares Atezolizumab, Roche / Genentech, Small-cell lung cancer, Non-small-cell lung cancer.
- TrialA Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Par
Shares Roche / Genentech, Pemetrexed, Cisplatin, Small-cell lung cancer.
- TrialA Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Particip
Shares Roche / Genentech, Pemetrexed, Cisplatin, Small-cell lung cancer.
- TrialA Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer
Shares Pemetrexed, Gemcitabine, Cisplatin, Small-cell lung cancer.
- TrialA Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Sm
Shares Pemetrexed, Gemcitabine, Cisplatin, Small-cell lung cancer.
- TrialA Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLC
Shares Vinorelbine, Docetaxel, Gemcitabine, Non-small-cell lung cancer.
- TrialSacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With
Shares Docetaxel, Pemetrexed, Small-cell lung cancer, Non-small-cell lung cancer.